These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study. Abolhasani S; Shahbazloo SV; Saadati HM; Mahmoodi N; Khanbabaei N Arq Bras Cardiol; 2019; 113(4):667-674. PubMed ID: 31482948 [TBL] [Abstract][Full Text] [Related]
28. Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. Inoue T; Uchida T; Kamishirado H; Takayanagi K; Hayashi T; Morooka S J Am Coll Cardiol; 2001 Mar; 37(3):775-9. PubMed ID: 11693751 [TBL] [Abstract][Full Text] [Related]
29. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease. Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905 [TBL] [Abstract][Full Text] [Related]
30. Particles and corrected particles of LDL and non-HDL are stronger predicters of coronary lesion in postmenopausal women. Li C; Chen J; Wei S; Zhang M; Chu Y; Meng F; Wang J; Tang J; Luo J; Yang Y; Niu X; Cai W BMC Cardiovasc Disord; 2021 Aug; 21(1):369. PubMed ID: 34340681 [TBL] [Abstract][Full Text] [Related]
31. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Sachdeva A; Cannon CP; Deedwania PC; Labresh KA; Smith SC; Dai D; Hernandez A; Fonarow GC Am Heart J; 2009 Jan; 157(1):111-117.e2. PubMed ID: 19081406 [TBL] [Abstract][Full Text] [Related]
32. Oxidized-LDL and paraoxonase-1 as biomarkers of coronary artery disease in patients with sleep-disordered breathing. Hackenhaar FS; Martinez D; Medeiros TM; Klein C; Alabarse PV; Wainstein MV; Gonçalves SC; Benfato MS Curr Med Chem; 2012; 19(25):4359-66. PubMed ID: 22934769 [TBL] [Abstract][Full Text] [Related]
33. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients. Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962 [TBL] [Abstract][Full Text] [Related]
34. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol. DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452 [TBL] [Abstract][Full Text] [Related]
35. Systemic Inflammatory Markers Are Closely Associated with Atherogenic Lipoprotein Subfractions in Patients Undergoing Coronary Angiography. Zhang Y; Li S; Xu RX; Zhu CG; Guo YL; Wu NQ; Sun J; Li JJ Mediators Inflamm; 2015; 2015():235742. PubMed ID: 26688615 [TBL] [Abstract][Full Text] [Related]
36. Non-HDL-C is a Better Predictor for the Severity of Coronary Atherosclerosis Compared with LDL-C. Zhang Y; Wu NQ; Li S; Zhu CG; Guo YL; Qing P; Gao Y; Li XL; Liu G; Dong Q; Li JJ Heart Lung Circ; 2016 Oct; 25(10):975-81. PubMed ID: 27634241 [TBL] [Abstract][Full Text] [Related]
37. Increased plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in patients with angiographically defined coronary artery disease. Mutlu-Türkoğlu U; Akalin Z; Ilhan E; Yilmaz E; Bilge A; Nişanci Y; Uysal M Clin Biochem; 2005 Dec; 38(12):1059-65. PubMed ID: 16226736 [TBL] [Abstract][Full Text] [Related]
38. Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease. You J; Wang Z; Lu G; Chen Z Biomed Res Int; 2020; 2020():7146028. PubMed ID: 32219140 [TBL] [Abstract][Full Text] [Related]
39. Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease. Miyazaki T; Shimada K; Sato O; Kotani K; Kume A; Sumiyoshi K; Sato Y; Ohmura H; Watanabe Y; Mokuno H; Daida H Atherosclerosis; 2005 Mar; 179(1):139-45. PubMed ID: 15721020 [TBL] [Abstract][Full Text] [Related]
40. Ratios of homocysteine and nitrite to high-density lipoprotein in coronary artery patients with the different degree of stenosis. Afrasyap L; Oztürk G Vascul Pharmacol; 2004 Apr; 41(3):91-6. PubMed ID: 15380734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]